Aim: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Early intervention in sepsis is vital and research on the subject continues. Having sedative, analgesic, and anxiolytic properties, Dexmedetomidine (DEX) is a potent lipophilic α2‐adrenoceptor agonist with imidazole structure. In recent years, there has been an increasing number of studies on the organ protective effects of DEX. Unlike other studies, in this project proposal, it was aimed to investigate the effect of DEX applied in different periods of sepsis on the oxidative stress index in the lungs, liver and heart. Material and methods: The study was approved by the Necmettin Erbakan University Experimental Animals Ethics Committee (2020 – 017). In the study, 50 female wistar albino rats were used as experimental animals. Animals were divided into five groups: 1st group: SHAM (n:10), 2nd group: SEPSIS (n:10), 3rd group: DEX (PreDEX, n:10) applied 30 minutes before cecal ligation puncture (CLP) procedure, group 4: DEX administered 12 hours after CLP (Post12DEX, n:10), group 5: DEX administered 24 hours after CLP (Post24DEX, n:10). Results: In liver and heart tissues, the decrease in total antioxidant status (TAS) levels in the SEPSIS group was statistically significant compared to the Post12DEX (p
Background/Objectives: Cervical facet joints are a common source of chronic neck pain, yet factors predicting treatment response to pulsed radiofrequency remain poorly defined. This study aimed to identify predictors of treatment success following ultrasound-guided cervical medial branch pulsed radiofrequency in patients with chronic cervical facet joint pain. Methods: This retrospective cohort study included 54 patients with chronic cervical facet joint pain who had positive response to diagnostic block. Pain intensity and functional disability were assessed at baseline and at 1-, 3-, and 6-months post-procedure, with treatment success defined as ≥50% pain reduction at 6 months. Results: The success rate was 35.2%, and multivariate logistic regression identified four independent predictors: presence of paraspinal tenderness on physical examination, shorter pain duration, lower baseline pain intensity, and lower baseline disability. Conclusions: These findings suggest that patients with localized facet joint pathology manifesting as paraspinal tenderness, shorter symptom duration, and lower baseline severity are most likely to benefit from this intervention, supporting early referral and careful clinical selection to optimize treatment outcomes.
26 September 2025 in OSMANGAZİ JOURNAL OF MEDICINE
Spinal cord stimulation (SCS) is an established neuromodulation technique for chronic pain management. This study evaluated outcomes and complications of SCS therapy across various chronic pain conditions. This retrospective, single-center cohort study analyzed 61 patients who received SCS implantation between January 2008 and December 2023. Treatment effectiveness was defined as a >50% reduction in Numeric Rating Scale (NRS) scores. Patient satisfaction was assessed using a 5-point Likert scale. Secondary outcomes included complications, revision requirements, and device longevity. Failed Back Surgery Syndrome (FBSS) was the most common indication (73.8%), followed by peripheral vascular disease (PVD) (8.2%). Overall treatment effectiveness was achieved in 90.2% of patients, with 100% success rates for complex regional pain syndrome (CRPS), PVD, phantom pain, peripheral nerve damage, spinal tumor, and stroke-related neuropathic pain. Among FBSS patients, 86.7% achieved significant pain reduction. Patient satisfaction was high, with 82.0% reporting positive satisfaction (67.2% very satisfied, 14.8% partially satisfied). Revision surgery was required in 16.4% of cases, treatment termination occurred in 8.2%, and implantable pulse generator replacement was necessary in 18.0%. Treatment failure rate was only 3.3%. SCS demonstrated high treatment effectiveness and patient satisfaction across various chronic pain conditions. The favorable safety profile with low treatment failure rates supports SCS as an important component of comprehensive pain management strategies when applied with appropriate patient selection criteria.
26 March 2026 in Turkish Journal of Intensive Care
Objective: This study evaluates the diagnostic performance of renal resistive index (RRI) and urinary cell cycle arrest biomarkers for early detection of sepsis-induced acute kidney injury (AKI) in a rat model using cecal ligation and puncture (CLP). Materials and Methods: Sixty female Wistar Albino rats were allocated into six groups (n=10): five CLP groups based on measurement timing (3, 6, 12, 24, and 48 hours post-procedure) and one sham group. Following CLP, RRI measurements were performed, and blood, urine, and tissue samples were collected before sacrifice. Urinary tissue inhibitor of metalloproteinase-2 (TIMP-2) and insulin-like growth factor binding protein-7 (IGFBP-7) were quantified via enzyme-linked immunosorbent assay (ELISA). Serum creatinine and lactate levels were measured, and histopathological kidney examination was conducted. Results: RRI increased significantly at six hours (0.44±0.04), peaking at 24 hours (0.73±0.02) post-CLP. The [TIMP-2×IGFBP-7] combination elevated significantly at three hours (P0.45 demonstrated optimal diagnostic accuracy (sensitivity 89%, specificity 87%). Conclusions: In this CLP-induced polymicrobial sepsis model, both RRI and urinary cell cycle arrest biomarkers predicted early AKI within similar timeframes, with RRI >0.45 showing superior predictive value.